Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Is Superior To Chemoimmunotherapy In Frontline Chronic Lymphocytic Leukemia (Cll): Pfs Co-Primary Endpoint Of The Randomized Phase 3 Gaia/Cll13 Trial
Obinutuzumab;Venetoclax;Ibrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Time-Limited Venetoclax-Obinutuzumab +/- Ibrutinib Is Superior To Chemoimmunotherapy In Frontline Chronic Lymphocytic Leukemia (Cll): Pfs Co-Primary Endpoint Of The Randomized Phase 3 Gaia/Cll13 Trial ### Output: Obinutuzumab;Venetoclax;Ibrutinib